NCT03731052View on ClinicalTrials.gov

Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307)

PHASE3CompletedINTERVENTIONAL
Enrollment

217

Participants

Timeline

Start Date

October 16, 2018

Primary Completion Date

December 20, 2019

Study Completion Date

December 20, 2019

Conditions
Plaque Psoriasis
Interventions
DRUG

188-0551 Spray

Topical Spray containing active drug

DRUG

Vehicle Spray

Topical Spray containing no active drug

Trial Locations (14)

14623

Site 07, Rochester

19103

Site 03, Philadelphia

20850

Site 13, Rockville

23502

Site 02, Norfolk

27262

Site 06, High Point

31217

Site 01, Macon

34470

Site 14, Ocala

48038

Site 10, Clinton Township

55432

Site 12, Fridley

60008

Site 11, Rolling Meadows

73071

Site 05, Norman

78229

Site 08, San Antonio

78759

Site 15, Austin

90045

Site 04, Los Angeles

All Listed Sponsors
lead

Therapeutics, Inc.

INDUSTRY

NCT03731052 - Comparison of 188-0551 Spray Versus Vehicle Spray in Subjects With Plaque Psoriasis (307) | Biotech Hunter | Biotech Hunter